Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
AACR 2020
Pharma
Roche's Tecentriq on top of Yescarta doesn't help clear cancer
By studying Yescarta plus Roche’s Tecentriq, Gilead aimed to find out if adding a PD-L1 drug to CAR-T therapy could help clear lymphoma. It didn't.
Carly Helfand
Apr 27, 2020 2:31am
Novartis' capmatinib tackles lung cancer in the brain: study
Apr 27, 2020 12:01am
Adding Roche's Tecentriq to Xtandi doesn't extend lives
Apr 27, 2020 12:01am
Roche's Tecentriq, on top of targeted drugs, stalls melanoma
Apr 27, 2020 12:01am
Merck pads case for convenient Keytruda dosing with new data
Apr 27, 2020 12:01am
